Collplant Biotechnologies Ltd (CLGN) Inventory Turnover Ratio, from fourth quarter 2025 to fourth quarter 2024, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Collplant Biotechnologies Ltd  (NASDAQ: CLGN)
 

Collplant Biotechnologies Ltd Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Collplant Biotechnologies Ltd inventory turnover ratio, the Collplant Biotechnologies Ltd's ability to sell and replace its inventory in the fourth quarter 2025, sequentially increased to 2.12 in the fourth quarter 2025, yet the ratio remained below the average, as CLGN's market remain challenging.Average inventory processing period, for the Collplant Biotechnologies Ltd in Dec 31 2025 quarter, has decreased to 172 days, compare to 227 days, in the 0 quarter.

Within Healthcare sector 161 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form in the third quarter 2025, to 1753.

CLGN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Collplant Biotechnologies Ltd Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CLGN Inventory Turnover Ratio (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Inventory Growth 88.31 % 159.28 % -8.69 % -19.75 % -82.3 %
Y / Y Cost of Sales Growth 55.78 % - - - -
Inventory Turnover Ratio (TTM) 2.12 - 7.53 - 7.71
CLGN's Total Ranking # 1753 # # # #
Average inventory processing period 172 - 49 - 47
Seq. Inventory Growth -49.39 % 15.99 % -13.79 % 272.08 % -30.32 %
Seq. Cost of Sales Growth - - - - -73.08 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 63
Healthcare Sector # 162
Overall Market # 1753

Inventory Turnover Ratio Statistics
High Average Low
10.55 4.07 0.73
(Dec 31 2024)   (Dec 31 2022)



CLGN Company Profile >> Back to CLGN Efficiency Comparisons >> Compare CLGN Inventory Turnover Ratio to its Competitors

Financial Statements
Collplant Biotechnologies Ltd's Inventories $ 0 Millions Visit CLGN's Balance sheet
Collplant Biotechnologies Ltd's Cost of Revenues TTM $ 1 Millions Visit CLGN's Income Statement
What are CLGN's Sales? Visit CLGN's Sales by Segment

Other Inventory Turnover Ratios
Collplant Biotechnologies Ltd's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CLGN's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CLGN's Competitors
Inventory Turnover Ratio for CLGN's Suppliers
Inventory Turnover Ratio for CLGN's Customers

You may also want to know
CLGN's Sales Growth Rates CLGN's Pe Price to earnings ratio CLGN's Receivables Turnover Ratio CLGN's Stock Quote
CLGN's Net Income Growth Rates CLGN's Ps Price to Sales ratio CLGN's Sales per Employee CLGN's Asset Turnover Ratio
CLGN's Net Margin CLGN's Pb Price to Book ratio CLGN's Financial Strength Ratios CLGN's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2025 Inventories at quarter ending Dec 31 2025
Concord Medical Services Holdings Ltd  9.35 $ 62.160  Millions$ 7  Millions
Lantheus Holdings Inc   9.29 $ 599.000  Millions$ 64  Millions
Carlsmed Inc   9.23 $ 12.110  Millions$ 1  Millions
National Vision Holdings Inc   9.22 $ 819.469  Millions$ 89  Millions
Sotera Health Company  9.20 $ 518.000  Millions$ 56  Millions
Alnylam Pharmaceuticals Inc   9.17 $ 677.166  Millions$ 74  Millions
Tarsus Pharmaceuticals Inc   9.11 $ 33.679  Millions$ 4  Millions
Warby Parker Inc   8.81 $ 401.000  Millions$ 45  Millions
Lifemd Inc   8.69 $ 27.000  Millions$ 3  Millions
Burning Rock Biotech Limited  8.67 $ 19.542  Millions$ 2  Millions
Castle Biosciences Inc   8.33 $ 71.028  Millions$ 9  Millions
Myriad Genetics Inc   8.29 $ 247.000  Millions$ 30  Millions
Cardiff Lexington Corporation  8.23 $ 4.442  Millions$ 1  Millions
Collegium Pharmaceutical Inc   8.19 $ 316.071  Millions$ 39  Millions
Charles River Laboratories International inc   7.90 $ 2,314.760  Millions$ 293  Millions
Pulse Biosciences Inc   7.87 $ 0.539  Millions$ 0  Millions
Adaptive Biotechnologies Corporation  7.75 $ 71.359  Millions$ 9  Millions
Inogen Inc   7.65 $ 194.403  Millions$ 25  Millions
Twist Bioscience Corporation  7.33 $ 189.423  Millions$ 26  Millions
Puma Biotechnology Inc   7.19 $ 58.157  Millions$ 8  Millions
Fonar Corporation  7.19 $ 19.805  Millions$ 3  Millions
Baird Medical Investment Holdings Limited  7.15 $ 3.653  Millions$ 1  Millions
Bellevue Life Sciences Acquisition Corp  6.84 $ 2.252  Millions$ 0  Millions
Carlisle Companies Incorporated  6.59 $ 3,227.300  Millions$ 490  Millions
Fresenius Medical Care Ag  6.57 $ 16,505.575  Millions$ 2,512  Millions
Vanda Pharmaceuticals Inc   6.53 $ 13.044  Millions$ 2  Millions
Edap Tms Sa  6.52 $ 95.511  Millions$ 15  Millions
Novavax inc   6.41 $ 73.040  Millions$ 11  Millions
Opko Health Inc   6.14 $ 400.939  Millions$ 65  Millions
Hims and Hers Health Inc   6.08 $ 614.000  Millions$ 101  Millions

Date modified: 2026-10-05T11:03:39+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.